GAREM2

Model summary

A soluble cytoplasmic adaptor that assembles and stabilizes growth-factor signaling complexes to potentiate ERK pathway output. Its N-terminal scaffold and C-terminal oligomerization module cooperatively bind proline-rich motifs, concentrating Ras–Raf–MEK–ERK components to amplify signaling triggered by epidermal growth factor and related inputs. By enhancing ERK1/2 cascade throughput, it promotes proliferative programs and operates primarily in the cytosol while transiently engaging membrane-proximal assemblies at the immunological synapse and the Golgi apparatus.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture.

   The N-terminal third harbors IPR025946 (CABIT domain, residues 29–309), a repeat-rich interaction module that typically forms a curved scaffold for assembling signaling complexes. The entire polypeptide is encompassed by IPR052281 (GRB2-associated and regulator of MAPK protein family, residues 9–874), which defines a lineage specialized for coupling to growth-factor pathways and the MAPK cascade. At the C-terminus lies IPR013761 (Sterile alpha motif/pointed domain superfamily, residues 805–871). SAM/pointed domains oligomerize and nucleate higher-order assemblies; in signaling adaptors, this architecture causes avid multivalent binding and spatial organization of pathway components. The ordered layout—an N-terminal CABIT scaffold feeding into a C-terminal SAM oligomerization hub—creates a bipartite adaptor that concentrates and stabilizes signaling complexes.

2. 02

   This architecture dictates the molecular function.

   CABIT-mediated scaffolding and a SAM-driven oligomerization interface together produce high-affinity, multivalent recognition of proline-rich motifs in partner proteins. Such assemblies directly support GO:0070064 proline-rich region binding, a hallmark of adaptor-mediated signal assembly in Ras–Raf–MEK–ERK pathways.

3. 03

   From this binding logic, the biological processes follow.

   By stabilizing adaptor and effector complexes downstream of receptor tyrosine kinases, the protein potentiates signal throughput through the ERK module, aligning with GO:0043410 positive regulation of MAPK cascade and GO:0070374 positive regulation of ERK1 and ERK2 cascade. Its coupling to growth-factor inputs places it squarely within GO:0007173 epidermal growth factor receptor signaling pathway and GO:0071364 cellular response to epidermal growth factor stimulus. Amplified ERK signaling drives entry into and progression through growth programs, explaining GO:0008284 positive regulation of cell population proliferation.

4. 04

   Cellular placement is a direct consequence of the scaffold’s soluble nature and its membrane-proximal clients.

   The absence of transmembrane segments and the presence of large interaction domains indicate a soluble adaptor that cycles between compartments. This supports a primary residence in the GO:0005829 cytosol, with dynamic recruitment to membrane-associated assemblies such as the GO:0001772 immunological synapse and trafficking hubs like the GO:0005794 Golgi apparatus. The experimentally observed cytoplasmic localization is consistent with this soluble scaffold that transiently associates with membrane-proximal complexes.

5. 05

   Mechanistically, the CABIT array nucleates assemblies by capturing proline-rich segments of adaptors and effectors, while the SAM domain oligomerizes the complex to raise local concentrations of Ras–Raf–MEK–ERK components.

   This cooperative assembly enhances pathway fidelity and amplitude. I hypothesize that the protein forms a central adaptor platform that binds GRB2 and related proline-rich adaptors, recruits SH3/SH2-containing effectors, and stabilizes Ras–MAPK modules near receptor and immune synapse sites. Likely partners include GRB2 and SOS1 (initiating Ras signaling), SHC1 and PTPN11/SHP2 (signal tuning), RAF1 and BRAF (ERK entry), MAPK1/MAPK3 and MAP2K1/MAP2K2 (cascade core), and membrane-proximal organizers at the Golgi and immunological synapse that guide spatially confined ERK activation and proliferative outputs.